The name of the issuer is Enovis Corporation, a Delaware corporation (the “Issuer”).
Item 1(b) | Address of Issuer’s Principal Executive Offices: |
The principal executive office of the Issuer is 2711 Centerville Road, Suite 400, Wilmington, Delaware 19808.
Item 2(a) | Name of Person Filing: |
This Schedule is being filed by Mitchell P. Rales (the “Reporting Person”).
Item 2(b) | Address of Principal Business Office, or, if None, Residence: |
The principal business address of the Reporting Person is 11790 Glen Road, Potomac, MD 20854.
The Reporting Person is a citizen of the United States of America.
Item 2(d) | Title of Class of Securities: |
This Schedule 13G/A relates to the common stock of the Issuer, par value $0.001 per share (the “Common Stock”).
The CUSIP Number of the Common Stock is 194014502.
Item 3 | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
N/A
As of December 31, 2022, the total number of shares of Common Stock beneficially owned by the Reporting Person is 1,798,851. 1,752,480 shares of Common Stock are held directly by the Reporting Person, 36,739 shares are held by the Mitchell P. Rales Family Trust, of which the Reporting Person is the trustee, and 9,362 shares are held in trust for his daughters, of which the Reporting Person is the trustee.
| (a) | Amount beneficially owned: 1,798,851 |
| (b) | Percent of class: 3.3%1 |
| (c) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote: 1,798,851 |
| (ii) | Shared power to vote or to direct the vote: -0- |
| (iii) | Sole power to dispose or to direct the disposition of: 1,798,851 |